Cross-sectional analysis of BioBank Japan clinical data: A large cohort of 200,000 patients with 47 common diseases
Background: To implement personalized medicine, we established a large-scale patient cohort, BioBank Japan, in 2003. BioBank Japan contains DNA, serum, and clinical information derived from approximately 200,000 patients with 47 diseases. Serum and clinical information were collected annually until...
Main Author: | Makoto Hirata |
---|---|
Format: | Article |
Language: | English |
Published: |
Japan Epidemiological Association
2017-03-01
|
Series: | Journal of Epidemiology |
Subjects: | |
Online Access: | https://www.jstage.jst.go.jp/article/jea/27/Supplement_III/27_27_S9/_pdf |
Similar Items
-
Overview of the BioBank Japan Project: Study design and profile
by: Akiko Nagai
Published: (2017-03-01) -
Clinical and histopathological characteristics of patients with prostate cancer in the BioBank Japan project
by: Shigekazu Ukawa
Published: (2017-03-01) -
Assessing and measuring financial sustainability model of the Spanish HIV HGM BioBank
by: Irene Consuegra Fernández, et al.
Published: (2020-01-01) -
Current status of umbilical cord blood storage and provision to private biobanks by institutions handling childbirth in Japan
by: Maho Murata, et al.
Published: (2022-09-01) -
Hybrid Zones, Bio-objectification and Microbiota in Human Breast Milk Banking
by: Carmen Romero-Bachiller, et al.
Published: (2019-01-01)